Rifaximin is a minimally absorbed antibiotic that is FDA-approved for treatment of travelers' diarrhea and prevention of hepatic encephalopathy.

Novartis (NVS) stock slips as the company's anti-inflammatory agent Cosentyx fails primary goal in a Phase 3 trial for giant cell arteritis. Read more here/ ...

Novartis and ProFound Therapeutics have entered into a four-year partnership aimed at discovering and developing new therapeutics for cardiovascular diseases (CVDs), with the deal worth $750m per ...

Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach ...

“We are thrilled to partner with Novartis, whose leadership in cardiovascular innovation is widely recognized across the industry,” said John Lepore, M.D., CEO of ProFound Therapeutics and ...

A memo that purports to summarize a meeting held by members of a biotech trade group suggests deep concern about RFK Jr.’s stance on vaccines ...

See the latest Sandoz Group AG Registered Shares stock price (SDZ:XSWX), related news, valuation, dividends and more to help you make your investing decisions.

Review the current Sandoz Group AG ADR (SDZNY:PINX) dividend yield and history to decide if SDZNY is the best investment for you.

This review focuses on current and future antibacterial drugs for the prevention and therapy of travelers' diarrhea, including the minimally absorbed antimicrobial drug rifaximin.